Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
119 Leser
Artikel bewerten:
(0)

Key Performance Metrics for Medical Affairs Organizations

CHAPEL HILL, N.C., April 4, 2014 /PRNewswire/ -- Charged with building and maintaining physician relationships, pharmaceutical Medical Affairs organizations typically oversee several important activities -- including publications, KOL programs, grants and medical education (CME) -- that have been impacted in recent years by a call for increased transparency. With the recent changes in the healthcare landscape, the Medical Affairs function has played an enormous role in guiding the healthcare sector's ongoing transition from simply drug marketing to dealing with a wide range of stakeholders who influence market access. As the importance of Medical Affairs continues to grow and the marketplace evolves, identifying and using key performance metrics to deliver value has become an important challenge for Medical Affairs organizations.

Best Practices LLC's weekly Medical Affairs Consortium research update has revealed that both emerging and mature market companies use a number of thought leader engagements and panels/presentations as the primary performance indicators for their Medical Affairs organization. Another important performance metric utilized by many organizations is external satisfaction surveys, which is used by 83% of the mature market benchmark class.

The weekly Medical Affairs Consortium research update provides leaders with an evidence-based understanding of current and evolving approaches to creating and maintaining a strong Medical Affairs function. This benchmarking research drew participation from 40 Medical Affairs leaders at 32 biopharma and device organizations. In addition, secondary research was conducted within Best Practices LLC's database to gather additional insights.

To learn more about Medical Affairs Consortium, click on the following link:http://www.best-in-class.com/medical-affairs-consortium.

For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website athttp://www.best-in-class.com/.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.